Related Experiment Videos
Serum ferritin in children with thalassaemia regularly transfused
Insights
Continuous chelation therapy in children with beta-thalassaemia significantly lowers iron overload markers. Serum ferritin levels correlate well with liver iron concentration, aiding in assessing iron overload in these patients.
Area of Science:
- Pediatric Hematology
- Iron Metabolism Disorders
- Chelation Therapy
Background:
- Homozygous beta-thalassaemia requires regular blood transfusions, leading to iron overload.
- Iron overload in these children can cause significant organ damage (tissue siderosis).
- Effective monitoring of iron overload is crucial for managing patients.
Purpose of the Study:
- To assess the effect of continuous chelation therapy on iron overload in regularly transfused children with homozygous beta-thalassaemia.
- To compare iron overload markers (serum ferritin, liver iron concentration) between chelated and control groups.
- To evaluate the utility of serum ferritin as a marker for visceral iron overload.
Main Methods:
- A controlled trial comparing chelation-treated children with non-chelated controls.
- Estimation of serum ferritin levels and liver iron concentrations in both groups.
- Statistical analysis to determine differences and correlations between measured parameters.
Main Results:
- Chelator-treated children showed lower serum ferritin levels and liver iron concentrations compared to controls.
- All participants exhibited high iron levels, comparable to untreated idiopathic haemochromatosis.
- A strong positive correlation was observed between serum ferritin and liver iron concentration.
Conclusions:
- Continuous chelation therapy is effective in reducing iron overload markers in beta-thalassaemia.
- Serum ferritin is a reliable indicator of visceral iron overload, even in cases of massive tissue siderosis.
- Monitoring serum ferritin provides a valuable, less invasive alternative to liver biopsy for assessing iron overload.
Abstract:
A controlled trial of continuous chelation therapy in regularly transfused children with homozygous beta-thalassaemia has been in progress at the Hospital for Sick Children since April 1966. In the sixth and seventh years of the trial the effect of this treatment on iron overload has been assessed by estimating serum ferritin levels and liver iron concentrations in both chelator-treated and control groups. When compared with non-chelated controls, results of both these estimations were invariably lower in the chelated group. However, all the results in both groups were very high, and fell within the ranges observed in untreated idiopathic haemochromatosis. A close correlation was found between serum ferritin levels and liver iron concentrations in these children, indicating that serum ferritin is a valuable alternative to liver iron concentration in the assessment of visceral iron overload, even when massive tissue siderosis is present.